Gilead Sciences, Inc. News Headlines

Get GILD Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
Portfolio Changes For The Third Quarter 2014
10/9/2014 9:14:00 AM - Seeking Alpha

Bristol-Myers Gives Up on US Approval of 2-Drug HCV Combo - Analyst Blog
10/8/2014 5:10:00 PM -

After Hours Most Active for Oct 8, 2014 : AA, REXX, QQQ, CS, GPS, CX, ABB, KMI, ZNGA, GILD, SIRI, MSFT
10/8/2014 3:44:53 PM - News

Called Strike 3 For Bristol-Myers Squibb: What This Says For Gilead And Its Competitors In The Hep C Market
10/8/2014 10:51:00 AM - Seeking Alpha

Bristol-Myers Tells Gilead Sciences, Inc. "You Win"
10/8/2014 10:05:02 AM - Motley Fool

ETF Outlook: Health Care Select Sector SPDR ETF (XLV)
10/8/2014 8:26:45 AM - Marc Chaikin

Biotech Stock Roundup: Sunesis Tanks on Study Results, Chimerix Up on Ebola Update - Analyst Blog
10/8/2014 7:14:00 AM -

Gilead Sciences: Hitch Your Wagon To This Biotech Juggernaut Before It Really Takes Off
10/7/2014 7:09:00 PM - Seeking Alpha

Comparing America's 2 Largest Biotechnology Companies
10/7/2014 1:57:00 PM - Seeking Alpha

It Is Getting Ugly Out There
10/7/2014 12:16:00 PM - Seeking Alpha

The Most Important Number You Need to Know Before Buying Gilead Sciences Inc. Stock
10/7/2014 10:05:02 AM - Motley Fool

A Professor Plans His Own EnDOWment Fund For Retirement
10/7/2014 9:58:00 AM - Seeking Alpha

HCV: The 'C' Stands For Cure
10/7/2014 1:31:00 AM - Seeking Alpha

After Hours Most Active for Oct 6, 2014 : ITUB, BAC, CX, PUK, HSBC, FTR, JDSU, HBAN, BID, GILD, SYMC, FITB
10/6/2014 3:39:52 PM - News

If Gilead's Hepatitis C Treatment Grosses $10B+ Per Year, Arrowhead's Hepatitis B Treatment Is Attractive.
10/6/2014 11:57:00 AM - Seeking Alpha

Gilead: Catalysts In Place For A Big October
10/6/2014 9:44:00 AM - Seeking Alpha

Gilead Sciences: Consolidation Before The Next Step Up
10/6/2014 9:41:00 AM - Seeking Alpha

Johnson & Johnson Takes Aim at Gilead Sciences, inc.
10/6/2014 8:03:03 AM - Motley Fool

Gilead Sciences' Other Important New Drug
10/5/2014 9:33:03 AM - Motley Fool

The Biggest Threat Facing Johnson & Johnson
10/4/2014 1:44:02 PM - Motley Fool

Gilead Sciences, Inc. Got 2 Drugs Approved, and Didn't Bother to Tell Anyone
10/4/2014 11:45:02 AM - Motley Fool

Better Dividend Stock: Merck & Co. Inc. or Bristol-Myers Squibb Co.?
10/4/2014 11:14:03 AM - Motley Fool

Individual Investor Portfolio: Major Sectors Are Beginning To Move In Opposing Directions
10/4/2014 3:39:00 AM - Seeking Alpha

MannKind Receives $150 Million Upfront Payment from Sanofi - Analyst Blog
10/3/2014 4:10:00 PM -

Regeneron-Sanofi's Dupilumab Meets All Endpoints - Analyst Blog
10/3/2014 2:00:00 PM -